Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
Condition(s):Kidney CancerLast Updated:February 5, 2009Completed
Hide Studies Not Open or Pending
Condition(s):Kidney CancerLast Updated:February 5, 2009Completed
Condition(s):Kidney CancerLast Updated:June 25, 2013Completed
Condition(s):Kidney CancerLast Updated:September 24, 2012Completed
Condition(s):Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell CancerLast Updated:January 24, 2013Completed
Condition(s):Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell CancerLast Updated:February 23, 2021Terminated
Condition(s):Recurrent Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7Last Updated:April 6, 2021Completed
Condition(s):Kidney Cancer; Stage III Renal Cell Cancer AJCC v8; Stage IV Renal Cell Cancer AJCC v8Last Updated:December 5, 2023Recruiting
Condition(s):Clear Cell Renal Cell Carcinoma; Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v8Last Updated:July 6, 2023Active, not recruiting
Condition(s):Kidney CancerLast Updated:October 4, 2023Terminated
Condition(s):Kidney CancerLast Updated:June 18, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.